Back to AVBP

GOLDMAN SACHS GROUP INC → AVBP

GOLDMAN SACHS GROUP INC AVBP Position History

ArriVent BioPharma, Inc. • Healthcare

Quarters held
14
Latest value
$292K
Q2 2026
Peak value
$18.4M
First seen
Q2 2025

Dollar value over time

Show data table
PeriodPosition value
Q2 2025$7.1M
Q2 2025$261K
Q3 2025$7.8M
Q3 2025$215K
Q4 2025$1.2M
Q4 2025$13.7M
Q4 2025$13.7M
Q4 2025$1.2M
Q1 2026$12.1M
Q1 2026$7.4M
Q1 2026$211K
Q2 2026$18.4M
Q2 2026$11M
Q2 2026$292K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$292K8.4K——
Q2 2026$11M315.3K——
Q2 2026$18.4M530.1K——
Q1 2026$211K9.1K——
Q1 2026$7.4M319.2K——
Q1 2026$12.1M525.0K——
Q4 2025$1.2M60.7K——
Q4 2025$13.7M681.9K——
Q4 2025$13.7M681.9K——
Q4 2025$1.2M60.7K——
Q3 2025$215K11.7K——
Q3 2025$7.8M420.3K——
Q2 2025$261K12.0K——
Q2 2025$7.1M327.2K——

Other funds holding AVBP

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B
AAPL

APPLE INC

$23.8B
AAPL

APPLE INC

$23.8B